Human Milk and Plasma Pharmacokinetics of Single-Dose Rimegepant 75 mg in Healthy Lactating Women

OBJECTIVE: Investigate whether rimegepant—an oral small molecule calcitonin gene-related peptide receptor antagonist for the treatment of migraine—is excreted in human milk after a single 75 mg dose and characterize its concentration–time profile in the plasma and milk of healthy lactating women to...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Teresa E., Croop, Robert, Kamen, Lisa, Price, Patty, Stock, David A., Ivans, Andrea, Bhardwaj, Rajinder, Anderson, Matt S., Madonia, Jennifer, Stringfellow, Joseph, Bertz, Richard, Coric, Vladimir, Hale, Thomas W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2022
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972016/
https://www.ncbi.nlm.nih.gov/pubmed/35049333
http://dx.doi.org/10.1089/bfm.2021.0250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972016/
https://www.ncbi.nlm.nih.gov/pubmed/35049333
http://dx.doi.org/10.1089/bfm.2021.0250

Ejemplares similares